ATNM
Actinium Pharmaceuticals Inc
1.10$
+1.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | 100.0% | – | – | 100.0% | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 595.7% | 14.6% | 400.0% | 491.1% | 141.2% | – | – | – | 245.7% | – | – | – | 25.2% | – | – | 228.9% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | -495.7% | 85.4% | -300.0% | -391.1% | -141.2% | – | – | – | -145.7% | – | – | – | -25.2% | – | – | 100.0% | – | – | 100.0% | 101.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 687.5% | 1,365.0% | 2,020.6% | 22,952.2% | 450.2% | 9,960.0% | 14,555.6% | 6,291.2% | – | – | – | 9,776.5% | – | – | – | 568.8% | – | – | 4,720.0% | – | – | 15.4% | 53.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 276.2% | 642.9% | 855.8% | 11,543.5% | 184.6% | 7,184.4% | 6,828.9% | 3,471.9% | – | – | – | 2,846.9% | – | – | – | 332.6% | – | – | 1,704.4% | – | – | 5.9% | 21.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 963.7% | 2,007.9% | 2,876.4% | 34,495.7% | 634.8% | 17,144.4% | 21,384.4% | 9,763.2% | – | – | – | 12,623.5% | – | – | – | 901.4% | – | – | 6,424.4% | – | – | 21.2% | 73.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -863.7% | -1,907.9% | -2,776.4% | -34,991.3% | -549.4% | -17,444.4% | -21,775.6% | -9,904.4% | – | – | – | -12,769.1% | – | – | – | -926.5% | – | – | -6,324.4% | – | – | 78.8% | 27.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.4% | 20.3% | 19.7% | 165.2% | 3.7% | 184.4% | 722.2% | 564.9% | – | – | – | 675.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -855.3% | -1,887.6% | -2,756.7% | -34,826.1% | -545.6% | -17,260.0% | -21,053.3% | -9,339.5% | – | – | – | -11,511.1% | – | – | – | -821.2% | – | – | -5,701.1% | – | – | 79.7% | 32.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.7% | -184.4% | -722.2% | -564.9% | – | – | – | 675.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -855.3% | -1,887.6% | -2,756.7% | -34,826.1% | -545.6% | -17,260.0% | -21,053.3% | -9,339.5% | – | – | – | -11,511.1% | – | – | – | -821.2% | – | – | -5,701.1% | – | – | 79.7% | 32.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -843.6% | -1,839.1% | -2,699.6% | -34,230.4% | -531.1% | -16,860.0% | -20,562.2% | -9,198.2% | – | – | – | -11,265.4% | – | – | – | -796.0% | – | – | -5,472.2% | – | – | 80.4% | 34.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.